Toi M - Search Results

1

Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.

Hattori M, Honma N, Nagai S, Narui K, Shigechi T, Ozaki Y, Yoshida M, Sakatani T, Sasaki E, Tanabe Y, Tsurutani J, Takano T, Saji S, Masuda S, Horii R, Tsuda H, Yamaguchi R, Toyama T, Yamauchi C, Toi M, Yamamoto Y. Hattori M, et al. Among authors: toi m. Breast Cancer. 2024 May;31(3):335-339. doi: 10.1007/s12282-024-01550-0. Epub 2024 Mar 4. Breast Cancer. 2024. PMID: 38433181 Free PMC article.

2

[Tumor angiogenesis in breast cancer: significance of vessel density as a prognostic indicator].

Toi M, Hoshina S, Yamamoto Y, Ishii T, Hayashi K, Tominaga T. Toi M, et al. Gan To Kagaku Ryoho. 1994 Jun;21 Suppl 2:178-82. Gan To Kagaku Ryoho. 1994. PMID: 7518660 Japanese.

3

Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer.

Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Toi M, et al. Int J Cancer. 1995 Apr 21;64(2):79-82. doi: 10.1002/ijc.2910640202. Int J Cancer. 1995. PMID: 7542228

4

Quantitative analysis of vascular endothelial growth factor in primary breast cancer.

Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T, Tominaga T. Toi M, et al. Cancer. 1996 Mar 15;77(6):1101-6. doi: 10.1002/(sici)1097-0142(19960315)77:6<1101::aid-cncr15>3.0.co;2-5. Cancer. 1996. PMID: 8635130

5

Regulation of endothelial growth factor expressions in breast cancer.

Toi M, Yamamoto Y, Taniguchi T, Saji S, Hayashi K, Tominaga T. Toi M, et al. Gan To Kagaku Ryoho. 1996 Mar;23 Suppl 1:75-9. Gan To Kagaku Ryoho. 1996. PMID: 8702315

6

[The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].

Saji S, Toi M, Tominaga T. Saji S, et al. Among authors: toi m. Nihon Geka Gakkai Zasshi. 1996 May;97(5):368-74. Nihon Geka Gakkai Zasshi. 1996. PMID: 8709939 Review. Japanese.

7

Increase in the circulating level of hepatocyte growth factor in gastric cancer patients.

Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A, Toi M. Taniguchi T, et al. Among authors: toi m. Br J Cancer. 1997;75(5):673-7. doi: 10.1038/bjc.1997.120. Br J Cancer. 1997. PMID: 9043023 Free PMC article.

8

Clinical significance of the determination of angiogenic factors.

Toi M, Taniguchi T, Yamamoto Y, Kurisaki T, Suzuki H, Tominaga T. Toi M, et al. Eur J Cancer. 1996 Dec;32A(14):2513-9. doi: 10.1016/s0959-8049(96)00397-8. Eur J Cancer. 1996. PMID: 9059341 Review. No abstract available.

9

Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma.

Suzuki A, Toi M, Yamamoto Y, Saji S, Muta M, Tominaga T. Suzuki A, et al. Among authors: toi m. Jpn J Cancer Res. 1998 Feb;89(2):221-7. doi: 10.1111/j.1349-7006.1998.tb00552.x. Jpn J Cancer Res. 1998. PMID: 9548451 Free PMC article.

10

Serum concentrations of hepatocyte growth factor in breast cancer patients.

Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y, Tominaga T. Taniguchi T, et al. Among authors: toi m. Clin Cancer Res. 1995 Sep;1(9):1031-4. Clin Cancer Res. 1995. PMID: 9816076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters